Omnicare Enters Pact with Pharmerica

Omnicare, Inc. OCR today confirmed that it has entered into a confidentiality and joint defense agreement with PharMerica Corporation PMC.  Under the agreement, the companies will exchange certain information in furtherance of the analysis of the regulatory approval process relating to Omnicare's previously announced offer to purchase all outstanding shares of PharMerica common stock for $15.00 per share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsContracts
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!